TrialEpilepsia2020

Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study.

Eugen Trinka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.